An Analysis of Financial Performance of Pharmaceutical Industry in India - A Study on NSE Listed Pharmaceutical Companies

Abstract

When the economy of entire world has been shattered by the sudden strike of Covid-19 Pandemic, Indian economy is still running with the help of Pharmaceutical Industry. It acts as a strong backbone of the economy. According to IKON Marketing Consultants! estimates, in the fiscal year, 2020-21 the Indian pharma industry is estimated to be worth $43 billion. In the last fiscal itself, the sector contributed around 1.72 per cent to the country’s GDP, making a significant mark. It was around one per cent a decade ago. In the case of exports, drugs and pharma products have recorded positive growth of 24.89 per cent during September 2020 vis-a-vis September 2019 amongst a few other commodity groups. The export of pharma products stood at $ 7,595 million and it remains the second-highest contributor with 7.79 per cent of total exports during April — Aug 2020, the Ist first being minerals with 8.94 per cent. Therefore, this study analyzes the present scenario of Indian Pharmaceutical Industry in terms of their financial performance.